Tom Edman
Analyst · Stifel
Thank you, Sameer. Good afternoon, and thank you for joining us for our fourth quarter 2020 conference call. These continue to be challenging times. And I hope that, all of you and your families are safe and healthy. I’ll begin with a review of our business strategy then an update on how COVID-19 has impacted our business followed by highlights from the quarter and a discussion of our fourth quarter results. Todd Schull, our CFO will follow with an overview of our Q4 2020 financial performance and our Q1 2021 guidance. We will then open the call to your questions. I am pleased to report that in the fourth quarter of 2020, TTM generated revenues above the midpoint of guidance and non-GAAP EPS above the guided range. All end markets performed better than guidance while year-on-year growth in the automotive and defense end markets was offset by weakness in the medical, industrial and instrumentation and networking and telecom end markets. In addition, continued strong operational execution, overcame production inefficiencies, and extra costs due to COVID-19. The COVID-19 pandemic has created operational difficulties, macroeconomic uncertainty, and employee concerns. I am extremely proud of how TTM employees have worked to deliver excellent performance, despite the formidable and unprecedented challenges of this environment. I’d also like to highlight that in Q4, we repaid and settled our $250 million convertible bond with no dilution to shareholders, solid cash flow from operations drove our net debt to EBITDA ratio to 1.4 at the end of Q4. Finally, we announced a $100 million share repurchase program as an additional tool to increase shareholder value following the strengthening of our balance sheet. For the full year of 2020, excluding the vested and closed businesses, TTM grew 3% with solid profitability despite headwinds from COVID-19 and the strengthening Chinese currency. Full year cash flow from operations was $287.2 million and along with the sale of the mobility business enabled us to repay debt and reduce leverage, putting us in a strong position for the future. Next, I would like to provide an update on our long-term strategy. TTM is on a journey to transform our business to be less cyclical and more differentiated. We believe over time investors will be rewarded with more stable growth, strong cash flow performance and improving margins. A key part of that strategy will be to add capabilities and products that are complementary to our current offerings both internally and through acquisitions. Looking forward, our balance sheet is in a strong position to pursue further acquisitions as well as to support our organic investment needs. I would also like to update you on the COVID situation. For the majority of 2020, we managed through COVID-19 with relatively minor impact to our production. Currently, the combination of colder weather in North America and the recent holiday season has created a surge of COVID cases. Since many of these infections are occurring in regions where our manufacturing locations or plants are located, we have also seen an increase of COVID cases within our employee population in North America. And we expect this condition to continue into 2021. While many of those that were infected returned to work after being cleared following testing and quarantine protocols. We still have a number of employees in quarantine, which is causing some production inefficiencies. We continue to conduct rapid testing, contact tracing, and to quarantine individuals who were in close contact with infected team members, in addition to deep cleaning effected work areas. We also continue other measures such as extensive internal communications, masking, temperature checks, and proper distancing in our facilities worldwide. Because of the stringent preventative measures in place and our culture of transparency and communications, these events have had less impact on our operations than might have been the case without these precautions. Now I’d like to review our end markets. All historical end market disclosures exclude the mobility business unit and the two EMS plants with healthy production in December. For more details on end market disclosures, please refer to our fourth quarter earnings press release and Pages 4 and 5 of our earnings presentation, both of which are posted on our website. The aerospace and defense end market represented 38% of total fourth quarter sales compared to 37% of Q4 2019 sales and 37% of sales in Q3 2020. We expect sales in Q1 from this end market to represent about 36% of our total sales. We saw solid growth in A&D segment with Q4 revenues up 2% year-on-year to a record high and an A&D record program backlog of $687 million compared to $600 million in the year ago quarter. Strength and defense more than offset weakness in the commercial aerospace end market. Growth in the defense market is a result of our strong strategic program alignment and key bookings for ongoing franchise programs. We saw significant bookings in the quarter for AESA radar systems; for Raytheon’s Army, Navy transportable surveillance radar to protect against ballistic missiles, Lockheed Slide 7, a variant of the U.S. LRDR program for the F-110 Spanish frigate; as well as Northrop upgrade of F-16 fighter jets with scalable agile beam radar. For the full year, aerospace and defense increased 7% and reached a record high as TTM benefited from increased defense spending and demand for multiple new programs. We were pleased to see the 2021 NDAA passed into law with bipartisan support, which suggests the defense budget could stay stable at a high level going forward. Given our solid program alignment, we would expect to outperform broader defense budget growth. In 2021, we expect growth to be in line with market projections of 2% to 4% driven by the defense side of our business. We expect the commercial aerospace portion, which was 16% of our A&D market in 2020 to be down in 2021. Automotive sales represented 17% of total sales during the fourth quarter of 2020, compared to 15% in the year ago quarter and 13% during the third quarter of 2020. Automotive grew almost 40% sequentially following the growth in Q3 and returned to year-on-year growth of 14%. We affect automotive to contribute 18% of total sales in Q1. For the full year, automotive declined 11% as both demand and supply were affected by COVID-19 in the first half of the year, followed by a recovery in the second half of the year. In 2020, advanced technology was 26% of our automotive end market compared to 20% in 2019. For the full year, we won design wins with a lifetime value of $629 million, compared to $475 million in 2019. In 2021, due to the anticipated stronger start, we expect the market to be above longer-term forecast of 3% to 6%. The medical industrial instrumentation end market contributed 16% of our total sales in the fourth quarter, compared to 17% in the year ago quarter and 19% in the third quarter of 2020. For the first quarter, we expect this market to be 16% of revenues. For the full year, AMI&I grew 12% well above the trend line due to strengthen our instrumentation customers specifically automated test equipment and strengthened our medical customers particularly for emergency requirements of printed circuit boards using ventilators and patient monitoring systems applied to the treatment of COVID-19. In 2021, we expect growth to be below the 2% to 4% forecast as these segments see moderated demand following the extraordinary strength of 2020. Networking communications accounted for 16% of revenue during the fourth quarter of 2020. This compares to 17% in the fourth quarter of 2019 and 17% of revenue in the third quarter of 2020. We saw relative strength in the networking segment compared to the telecom segment as 5G builds pause temporarily. In Q1, we expect this end market to be 15% of revenue, due primarily to uncertainty around the timing and ramp of Phase 3 build for 5G in China. For the full year, networking communications declined 4%. We expect this market to grow, but be below the longer term forecast of 5% to 8% growth in 2021, due to the anticipated soft start in the early part of the year, followed by a ramp of 5G infrastructure needs in the back half of the year, complimented by growth in networking. Sales in the computing storage peripherals end market represented 13% of total sales in the fourth quarter compared to 13% in Q4 of 2019 and in the third quarter of 2020. This end market was up 2% year-on-year as growth in our semiconductor customers offset modest year-on-year declines from our data center customers. We expect revenues in this end market to represent approximately 14% of first quarter sales. For the full year, computing grew 9% as we saw growth across our data center and semiconductor customers. In 2021, we expect to be above the forecasted end market growth of 1% to 3%, driven primarily by data center growth. Next I’ll cover some details from the fourth quarter. Note that all of the following operations metrics exclude the mobility business unit and the two EMS plants that we closed. This information is also available on Page 6 of our earnings presentation. During the quarter, our advanced technology business, which includes HDI, rigid flex and RF subsystems and components accounted for approximately 31% of our revenue. This compares to approximately 27% in the year ago quarter and 29% in Q3. We are continuing to pursue new business opportunities and increase customer design engagement activities that will leverage our advanced technology capabilities in new markets. Capacity utilization in Asia Pacific was 63% in Q4 compared to 61% in the year ago quarter and 63% in Q3. Our overall capacity utilization in North America was 58% in Q3 compared to 58% in the year ago quarter and 61% in Q3. Our top five customers contributed 34% of total sales in the fourth quarter of 2020 compared to 36% in the third quarter of 2020. Our largest customer accounted for 14% of sales in the fourth quarter. At the end of Q4, our 90-day backlog, which is subject to cancellations was $483.9 million compared to $402.8 million at the end of the fourth quarter last year and $437.8 million at the end of Q3. Our PCB book-to-bill ratio was 1.19 for the three months ending December 28. I’d like to conclude by again thanking our employees for continuing to contribute to TTM and our critical mission of inspiring innovation with our customers. Their efforts are particularly appreciated during these times by our customers in critical essential areas like defense and the medical industries. Despite the COVID-19 and currency related challenges we faced in 2020, our business performed better than we expected as a direct result of operational excellence and market diversification and our employees concerted efforts to engage and support our customers. We’ve also taken positive strategic moves that will strengthen TTM for the long-term. Now, Todd will review our financial performance for the fourth quarter. Todd?